Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia
Gail J. Roboz(Cornell University), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Theresa Y. MacDonald(NewYork–Presbyterian Hospital), Kenneth Eng(Cornell University), Jaclyn A. Croyle(Cornell University), Rohan Bareja(Cornell University), David S. Rickman(Cornell University), Mark A. Rubin(University of Bern), Jenny Xiang(Cornell University), Gabriela Chiosis(Memorial Sloan Kettering Cancer Center), Koen van Besien(University Hospitals of Cleveland), Zohal Noorzad(Cornell University), Juan Miguel Mosquera(NewYork–Presbyterian Hospital), Andrea Sboner(Cornell University), Himisha Beltran(Dana-Farber Cancer Institute), Olivier Elemento(Cornell University), Sarah Nataraj(Cornell University), Wayne Tam(Cornell University), LunBiao Yan(Cornell University), Reyna A Jimenez-Flores(Cornell University), Luke C. Olson(Cornell University), David Wilkes(Cornell University), Shuhua Cheng(Cornell University), Bob Morgan, Duane C. Hassane(AstraZeneca (Singapore)), Danielle Pancirer(Cornell University), Mayumi Sugita(Cornell University)
Cited by 3
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k